
|Articles|December 20, 2001
CDER Drug Approvals
Author(s)BioPharm International Editors
Drug Approvals [Includes Drug Label and Approval Letter] (Updated 12/18/2001)
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
4
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
5





